Avadel Pharmaceuticals (AVDL) Short Interest Ratio & Short Volume $11.66 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Avadel Pharmaceuticals Short Interest DataAvadel Pharmaceuticals (AVDL) has a short interest of 9.45 million shares. This marks a -7.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.1, indicating that it would take 10.1 days of the average trading volume of 1.19 million shares to cover all short positions.Current Short Interest9,450,000 sharesPrevious Short Interest10,190,000 sharesChange Vs. Previous Month-7.26%Dollar Volume Sold Short$146.19 millionShort Interest Ratio10.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares96,270,000 sharesPercentage of Shares Shorted9.82%Today's Trading Volume1,576,841 sharesAverage Trading Volume1,193,885 sharesToday's Volume Vs. Average132% Short Selling Avadel Pharmaceuticals? Sign up to receive the latest short interest report for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVDL Short Interest Over TimeAVDL Days to Cover Over TimeAVDL Percentage of Float Shorted Over Time Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Avadel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20249,450,000 shares $146.19 million -7.3%N/A10.1 $15.47 10/15/202410,190,000 shares $134.51 million -7.1%N/A11.5 $13.20 9/30/202410,970,000 shares $143.82 million -5.9%N/A11.8 $13.11 9/15/202411,660,000 shares $159.74 million -2.1%N/A9.2 $13.70 8/31/202411,910,000 shares $180.67 million +1.2%N/A9.4 $15.17 8/15/202411,770,000 shares $180.67 million +3.5%N/A9.8 $15.35 Get the Latest News and Ratings for AVDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202411,370,000 shares $185.79 million -5.5%N/A8.7 $16.34 7/15/202412,030,000 shares $199.22 million +42.0%N/A9.4 $16.56 6/30/20248,470,000 shares $119.09 million +17.6%N/A6.3 $14.06 6/15/20247,200,000 shares $113.83 million +11.1%N/A7.2 $15.81 5/31/20246,480,000 shares $103.36 million +14.1%N/A6.9 $15.95 5/15/20245,680,000 shares $91.39 million +18.3%N/A4.5 $16.09 4/30/20244,800,000 shares $87.17 million -54.8%N/A3.8 $18.16 4/15/202410,610,000 shares $0.00 +2.1%N/A8.7 $0.00 3/31/202410,390,000 shares $175.49 million -0.8%N/A8.4 $16.89 3/15/202410,470,000 shares $166.68 million -2.5%N/A8.2 $15.92 2/29/202410,740,000 shares $137.26 million +21.2%N/A8.5 $12.78 2/15/20248,860,000 shares $125.81 million +4.5%N/A9.2 $14.20 1/31/20248,480,000 shares $122.03 million +30.1%N/A9.2 $14.39 1/15/20246,520,000 shares $96.50 million +26.6%N/A7.7 $14.80 12/31/20235,150,000 shares $72.72 million +2.2%N/A6.8 $14.12 12/15/20235,040,000 shares $70.51 million +6.1%N/A7.5 $13.99 11/30/20234,750,000 shares $54.82 million -0.4%N/A7.6 $11.54 11/15/20234,770,000 shares $52.09 million +19.3%N/A8.3 $10.92 10/31/20234,000,000 shares $39.44 million +4.4%N/A6.9 $9.86 10/15/20233,830,000 shares $40.29 million +0.8%N/A6.8 $10.52 9/30/20233,800,000 shares $39.14 million +13.8%N/A6.6 $10.30 9/15/20233,340,000 shares $40.98 million +28.0%N/A5 $12.27 8/31/20232,610,000 shares $35.26 million -15.3%N/A3.5 $13.51 8/15/20233,080,000 shares $42.38 million -1.0%N/A3.9 $13.76 7/31/20233,110,000 shares $43.85 million -8.5%N/A3.7 $14.10 7/15/20233,400,000 shares $52.33 million -8.6%N/A3.4 $15.39 6/30/20233,720,000 shares $61.31 million -21.4%N/A3.8 $16.48 6/15/20234,730,000 shares $70.00 million +16.8%N/A4.6 $14.80 5/31/20234,050,000 shares $56.09 million +20.9%N/A4.4 $13.85 5/15/20233,350,000 shares $48.61 million -13.9%N/A3.7 $14.51 4/30/20233,890,000 shares $40.77 million +4.6%N/A4.5 $10.48 4/15/20233,720,000 shares $36.87 million +24.0%N/A5.8 $9.91 3/31/20233,000,000 shares $27.48 million -24.1%N/A4.9 $9.16 3/15/20233,950,000 shares $36.26 million -0.3%6.9%9 $9.18Missed Nvidia? Watch this ASAP (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. 2/28/20233,960,000 shares $39.40 million +0.3%7.3%7.9 $9.95 2/15/20233,950,000 shares $33.58 million +7.9%7.2%7.5 $8.50 1/31/20233,660,000 shares $27.54 million +9.6%6.5%6.1 $7.53 1/15/20233,340,000 shares $22.98 million -17.5%5.9%5.4 $6.88 12/30/20224,050,000 shares $29.00 million +3.3%7.1%6.8 $7.16 12/15/20223,920,000 shares $26.93 million +0.8%6.9%5.3 $6.87 11/30/20223,890,000 shares $35.67 million -2.5%6.9%5.7 $9.17 11/15/20223,990,000 shares $32.12 million -1.0%7.0%6.1 $8.05 10/31/20224,030,000 shares $26.56 million -1.2%7.3%7 $6.59 10/15/20224,080,000 shares $24.60 million +7.9%7.4%6.7 $6.03 9/30/20223,780,000 shares $18.94 million -4.6%6.9%5.3 $5.01 9/15/20223,960,000 shares $23.64 million +2.1%7.2%5.4 $5.97 8/31/20223,880,000 shares $25.76 million -14.0%7.1%4.8 $6.64 8/15/20224,510,000 shares $30.98 million -4.0%8.2%1.2 $6.87 7/31/20224,700,000 shares $22.23 million -12.2%8.7%1.2 $4.73 7/15/20225,350,000 shares $25.25 million -5.5%13.5%1.3 $4.72 6/30/20225,660,000 shares $13.81 million -5.0%14.2%1.4 $2.44 6/15/20225,960,000 shares $13.77 million +42.6%15.0%1.6 $2.31 5/31/20224,180,000 shares $9.24 million +7.2%8.3%1.1 $2.21 5/15/20223,900,000 shares $14.82 million -6.0%7.8%6.4 $3.80 4/30/20224,150,000 shares $20.75 million +4.8%8.2%7 $5.00 4/15/20223,960,000 shares $26.85 million -15.2%7.9%10 $6.78 3/31/20224,670,000 shares $31.90 million +7.1%9.3%11 $6.83 3/15/20224,360,000 shares $30.04 million -3.8%8.7%10.1 $6.89 2/28/20224,530,000 shares $36.51 million -11.2%9.1%10.4 $8.06 2/15/20225,100,000 shares $35.65 million +4.5%10.2%11.7 $6.99 1/31/20224,880,000 shares $29.38 million +1.7%9.8%10.3 $6.02 1/15/20224,800,000 shares $31.01 million +4.6%9.6%9.3 $6.46 12/31/20214,590,000 shares $37.09 million +10.3%9.1%6.5 $8.08 12/15/20214,160,000 shares $31.12 million -2.1%8.2%5.7 $7.48 11/30/20214,250,000 shares $38.08 million -11.1%8.4%5.8 $8.96 11/15/20214,780,000 shares $52.72 million +29.9%9.4%6.8 $11.03 10/29/20213,680,000 shares $35.73 million +3.7%6.8%5.5 $9.71 10/15/20213,550,000 shares $35.46 million +2.3%6.5%6.2 $9.99 9/30/20213,470,000 shares $34.01 million -7.0%6.4%9.7 $9.80 9/15/20213,730,000 shares $29.24 million +1.4%6.8%12.7 $7.84 8/31/20213,680,000 shares $30.51 million +1.1%6.8%14.1 $8.29 8/13/20213,640,000 shares $29.37 million -6.4%6.7%14.1 $8.07 7/30/20213,890,000 shares $30.23 million No Change7.2%13.9 $7.77 7/15/20213,890,000 shares $26.18 million +0.5%7.2%14.3 $6.73 6/30/20213,870,000 shares $26.05 million -8.7%7.1%14.4 $6.73 6/15/20214,240,000 shares $31.76 million +0.2%7.8%17.3 $7.49 5/28/20214,230,000 shares $32.53 million +7.1%7.8%15.7 $7.69 5/14/20213,950,000 shares $31.52 million +1.0%N/A11.4 $7.98 4/30/20213,910,000 shares $30.69 million -2.0%N/A9.1 $7.85 4/15/20213,990,000 shares $35.03 million +1.8%N/A8.1 $8.78 3/31/20213,920,000 shares $34.77 million -8.8%N/A7.8 $8.87 3/15/20214,300,000 shares $42.01 million -6.1%N/A7.5 $9.77 2/26/20214,580,000 shares $38.75 million +21.5%N/A8.1 $8.46 2/12/20213,770,000 shares $34.27 million +9.3%N/A6.9 $9.09[Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. 1/29/20213,450,000 shares $26.19 million -10.4%N/A6.7 $7.59 1/15/20213,850,000 shares $25.45 million -3.3%N/A8.1 $6.61 12/31/20203,980,000 shares $26.63 million -3.2%N/A8.7 $6.69 12/15/20204,110,000 shares $30.87 million -6.4%N/A8.6 $7.51 11/30/20204,390,000 shares $32.79 million +2.3%N/A7.3 $7.47 11/15/20204,290,000 shares $27.67 million +3.1%N/A5.8 $6.45 10/30/20204,160,000 shares $21.59 million +4.5%N/A5.3 $5.19 10/15/20203,980,000 shares $21.25 million -1.5%N/A5 $5.34 9/30/20204,040,000 shares $20.36 million -36.2%N/A4.8 $5.04 9/15/20206,330,000 shares $33.23 million -0.5%N/A7.2 $5.25 8/31/20206,360,000 shares $46.49 million +4.8%N/A8.5 $7.31 8/14/20206,070,000 shares $48.01 million +9.6%N/A9.5 $7.91 7/31/20205,540,000 shares $43.38 million +10.1%N/A8.4 $7.83 7/15/20205,030,000 shares $38.53 million -2.7%N/A5.6 $7.66 6/30/20205,170,000 shares $41.05 million +13.9%N/A5.8 $7.94 6/15/20204,540,000 shares $38.68 million -11.7%N/A5.4 $8.52 5/29/20205,140,000 shares $41.53 million -8.9%N/A5.8 $8.08 5/15/20205,640,000 shares $45.57 million -14.4%N/A6.1 $8.08 4/30/20206,590,000 shares $68.40 million +1.4%19.0%7 $10.38 4/15/20206,500,000 shares $64.22 million +47.7%18.8%8.9 $9.88 3/31/20204,400,000 shares $43.25 million +11.3%12.7%5.7 $9.83 3/13/20203,953,100 shares $37.55 million -43.9%11.4%5.5 $9.50 2/28/20207,050,000 shares $49.07 million +12.6%20.4%8.4 $6.96 2/14/20206,260,000 shares $53.65 million -8.1%N/A7.8 $8.57 1/31/20206,810,000 shares $70.48 million +2.1%18.9%10.2 $10.35 1/15/20206,670,000 shares $50.29 million -3.9%N/A10.4 $7.54 12/31/20196,940,000 shares $47.82 million +2.4%N/A12 $6.89 AVDL Short Interest - Frequently Asked Questions What is Avadel Pharmaceuticals' current short interest? Short interest is the volume of Avadel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 9,450,000 shares of AVDL short. Learn More on Avadel Pharmaceuticals' current short interest. What is a good short interest ratio for Avadel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVDL shares currently have a short interest ratio of 10.0. Learn More on Avadel Pharmaceuticals's short interest ratio. Which institutional investors are shorting Avadel Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avadel Pharmaceuticals: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Vestal Point Capital LP, Walleye Capital LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avadel Pharmaceuticals' short interest increasing or decreasing? Avadel Pharmaceuticals saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 9,450,000 shares, a decrease of 7.3% from the previous total of 10,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avadel Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avadel Pharmaceuticals: Collegium Pharmaceutical, Inc. (19.87%), Bicycle Therapeutics plc (6.88%), Immunic, Inc. (5.00%), Ovid Therapeutics Inc. (1.16%), BridgeBio Pharma, Inc. (11.71%), Ultragenyx Pharmaceutical Inc. (3.44%), Immunovant, Inc. (21.05%), Organon & Co. (5.51%), Rhythm Pharmaceuticals, Inc. (13.60%), ImmunityBio, Inc. (33.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Avadel Pharmaceuticals stock? Short selling AVDL is an investing strategy that aims to generate trading profit from Avadel Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avadel Pharmaceuticals? A short squeeze for Avadel Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVDL, which in turn drives the price of the stock up even further. How often is Avadel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVDL, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies COLL Short Interest BCYC Short Interest IMUX Short Interest OVID Short Interest BBIO Short Interest RARE Short Interest IMVT Short Interest OGN Short Interest RYTM Short Interest IBRX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVDL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVDL Stock Alerts